Davide Campana
Università degli Studi di Bologna
H-index: 41
Europe-Italy
Top articles of Davide Campana
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study
Journal of Endocrinological Investigation
2024/4/29
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort
Journal of Clinical Medicine
2024/4/3
Giuseppe Lamberti
H-Index: 13
Davide Campana
H-Index: 25
OC. 06.3: ITANET NATIONAL PROSPECTIVE DATABASE: A COMPREHENSIVE ANALYSIS OF EPIDEMIOLOGY AND CLINICAL PRESENTATION OF GEP-NEN IN ITALY
Digestive and Liver Disease
2024/4/1
Safety and efficacy of endoscopic ultrasound‐guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta‐analysis
2024/4
Pietro Fusaroli
H-Index: 24
Davide Campana
H-Index: 25
Real-Life Use of [68Ga] Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in …
Cancers
2024/2/7
Davide Campana
H-Index: 25
Giuseppe Lamberti
H-Index: 13
Riccardo Casadei
H-Index: 28
Claudio Ricci
H-Index: 24
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for …
2024/1/4
Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms
Nutrients
2023/8/29
Davide Campana
H-Index: 25
Diego Ferone
H-Index: 39
An update on appendiceal neuroendocrine tumors
2023/7
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm
The Lancet Oncology
2023/5/1
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
Diagnostics
2023/4/29
Giuseppe Lamberti
H-Index: 13
Dario De Biase
H-Index: 27
Rossana Berardi
H-Index: 37
Davide Campana
H-Index: 25
BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature
2023/4/28
Davide Campana
H-Index: 25
Giuseppe Lamberti
H-Index: 13
Role of endoscopic resection margin (R1) in the clinical outcome of patients with Neuroendocrine Neoplasia
Endoscopy
2023/4
T. 08.1 ROLE OF ENDOSCOPIC RESECTION MARGIN (R1) IN THE CLINICAL OUTCOME OF PATIENTS WITH NEUROENDOCRINE NEOPLASIA
Digestive and Liver Disease
2023/3/1
Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis
Langenbeck's Archives of Surgery
2023/1/25
Claudio Ricci
H-Index: 24
Davide Campana
H-Index: 25
Giuseppe Lamberti
H-Index: 13
Riccardo Casadei
H-Index: 28
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated …
Current Oncology
2023/1/18
Giuseppe Lamberti
H-Index: 13
Davide Campana
H-Index: 25
Chemotherapy in well differentiated neuroendocrine tumors (NET) G1, G2, and G3: a narrative review
2023/1/16
Davide Campana
H-Index: 25
Giuseppe Lamberti
H-Index: 13
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives
2023/12/15
Davide Campana
H-Index: 25
Giuseppe Lamberti
H-Index: 13
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II …
BMC cancer
2023/9/26
Davide Campana
H-Index: 25
Large cell neuroendocrine carcinoma of the lung: current understanding and challenges
2022/3/7
